Congenital afibrinogenaemia is an autosomal recessive disorder characterised by the complete absence of detectable fibrinogen. We previously identified the first known causative mutations for this disorder in a non-consanguineous Swiss family. The four affected male individuals (two brothers and their first two cousins) were shown to have homozygous deletions of approximately 11 kb of the fibrinogen alpha chain (FGA) gene. Haplotype data suggested that the deletions occurred on three distinct ancestral chromosomes, implying that the FGA region of the fibrinogen locus is susceptible to deletion by a common mechanism, but the sequences responsible for the recombination remained to be identified. Here, we report the detailed characterisation of the deletion by nucleotide sequence analysis of all three deletion junctions and comparison with normal sequences. We found that all three deletions were identical to the base-pair and probably resulted from non-homologous (illegitimate) recombination. The centromeric and telomeric deletion junctions featured both a 7 bp direct repeat, AACTTTT, situated in FGA intron 1 and in the FGA-FGB intergenic sequence and a number of inverted repeats which could be involved in the generation of secondary structures. Analysis with closely linked flanking polymorphic markers revealed the existence of at least two haplotypes, further suggesting independent origins of the deletions in this family.
Introduction
Congenital afibrinogenaemia (Mendelian Inheritance in Man, 202400) is a rare, autosomal recessive disorder characterised by the complete absence of detectable fibrinogen and was originally described in 1920. 1 To date some 150 families with this disorder have been reported 2 with approximately 50% of cases present in consanguineous pedigrees. 3 Despite the fact that functional assays of clot formation are infinitely prolonged, the coagulation defect is surprisingly no more severe than in the haemophilias A and B, varying from severe to mild. Uncontrolled bleeding after birth from the umbilical cord is common, and spontaneous intra-cerebral bleeding and splenic rupture can occur throughout life. Patients generally respond well to replacement therapy with purified human fibrinogen.
The fibrinogen gene family is comprised of three genes coding for fibrinogen gamma (FGG), alpha (FGA) and beta (FGB), clustered in a region of approximately 50 kb on chromosome 4q28-q31. 4 We have previously studied this region by microsatellite analysis, PCR amplification, and Southern blotting in a non-consanguineous Swiss family with four affected individuals (two brothers and their first cousins), identifying the first known causative mutations for congenital afibrinogenaemia. 5 All affected individuals were found to be homozygous for a deletion of approximately 11 kb of DNA which eliminates the majority of the FGA gene. The nature of the mutation identified confirmed that humans can survive despite totally lacking the capacity to synthesise active fibrinogen, as can the fibrinogen knock-out mice 6 generated by disruption of FGA exon 1. Interestingly, haplotype data implied that the deletions occurred as separate historical events, on three different ancestral chromosomes, suggesting a common molecular mechanism leading to recurrent mutation. 5 We wished to identify the molecular mechanism involved in the generation of the deletions responsible for congenital afibrinogenaemia. Although the centromeric breakpoints of all deletions were known to occur within FGA intron 1, the exact sequence of the deletion junctions was unknown since the telomeric end of the deletions, as determined by the size of the deletion measured in Southern blots, was situated in the previously uncharacterised intergenic FGA-FGB region.
Here we report the cloning of the FGA-FGB intergenic region following long-range PCR, and the sequencing of the deletion junctions for all mutated chromosomes. We found that all three deletions were identical to the base-pair and probably resulted from non-homologous (illegitimate) recombination, mediated by direct and possibly indirect repeats in the breakpoint region.
Methods

Patients
The four adult male patients with congenital afibrinogenaemia and their family have been described in detail by Neerman-Arbez et al. 5 
Long-range PCR Amplification and Cloning of the
FGA-FGB Intergenic Sequence
A first long-range PCR amplification with primers FGAN1 and FGBN1 (Table 1) was performed from genomic DNA from affected individuals in a total volume of 100 µl with ExTaq (Takara, distributed by Axon Lab, Baden Dättwil, Switzerland) according to the manufacturer's protocol, with betaine (Qiagen Q, Basel, Switzerland) solution included in the reaction mix. The amplification programme was: 94°C, 1 min; followed by 98°C, 20 s; 68°C, 20 min (14 cycles) and 98°C, 20 s; 68°C, 20 min + 15 s/cycle (16 cycles). A final elongation step at 72°C for 10 min was performed. Nested forward primers were designed from the sequence for FGA (Genbank accession number M64982) and nested reverse primers from FGB (Genbank M64983); for primer sequences see Table 1 .
For the nested amplification, 20 µl of the first reaction was used in a total volume of 100 µl as before, with primers FGAN2 and FGBN2. The amplified fragment obtained from affected individuals (homozygous for the deletion) or carriers (heterozygous for the deletion) was approximately 11.5 kb (Figure 1 ). This product was cloned using the TOPO-XL cloning method (Invitrogen, Groningen, The Netherlands).
To obtain the centromeric portion of the FGA-FGB intergenic sequence, we performed a single-round PCR amplification from genomic DNA from heterozygous individuals using a forward primer in FGA exon 5 (FGA ϫ 5L) and a reverse primer designed from the novel intergenic sequence, FGbreak1R. After denaturation at 94°C, the amplification programme consisted of 10 touchdown cycles of 30 s denaturation at 94°C, 30 s annealing between 60 and 50°C and 10 min elongation at 72°C followed by 20 cycles (30 s at 94°C, 30 s at 50°C, 10 min at 72°C). The enzyme used was ExTaq (TaKaRa). The amplified product from the normal, nondeleted allele, approximately 7 kb, was also cloned in the TOPO-XL vector (Invitrogen. Groningen, The Nertherlands).
PCR Amplification and Sequencing of the Deletion Junctions
PCR amplification of the deletion junction from all patients and from carrier individuals was performed with primers FGA ϫ 1L and FGbreak1R. Sequences were obtained with the primers used for the amplification with a semi-automated sequencer (ABI 377; Perkin-Elmer Applied Biosystems),
Table 1 List of oligonucleotide primers
Primer
Sequence 5Ј-3Ј
GGGTGTGATAATATACATTC using standard protocols. The novel 1094 bp sequence surrounding the breakpoint in the FGA-FGB intergenic sequence has been submitted to Genbank (accession number AF145725).
Secondary Structure Prediction
The sequences around the deletion junctions were analysed for secondary structures with the mfold program (http:/ /mfold2.wustl.edu/~mfold/dna/form1.cgi).
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Deletion Carrier Screening
A total of 468 anonymised DNA samples isolated from buccal smears from unrelated individuals from the Geneva region were analysed for the presence of the deletion junction by PCR amplification with primers FGA ϫ 1L and FGbreak1R and for the control normal band with a second reverse primer FGAi1AR. A nested PCR was performed with primers FGAi1AL and FGbreak2R (for the deletion) and FGAi1BR (for the normal band). The PCR products were then dotblotted and hybridised with a 32 P end-labelled internal oligonucleotide (FGAi1DL for the normal product, FGbreak3R for the deletion), under standard conditions.
Chromosome 4 Microsatellite Analysis
DNA extractions and microsatellite analysis were performed as previously described. 8 The new markers used for haplotype analysis were D4S3021, D4S2999, D4S2631 and D4S3016. The markers were located to either side of the FGA gene, covering a total area of 5 centimorgans (Marshfield sexaveraged genetic map, http://www.marshmed.org). The locus order and genetic distances in Kosambi centimorgans were as follows:
Results
The fibrinogen locus is comprised of single copies of three genes coding for fibrinogen gamma (FGG), alpha (FGA) and beta (FGB), clustered in a region of approximately 50 kb on chromosome 4q28-q31, 4 (Figure 1) . The sequences of the three fibrinogen genes, and that of the intergenic region between FGG and FGA have been previously determined (Genbank accession numbers: alpha M64982; beta M64983; gamma M10014; FGG-FGA intergenic U36478). In contrast the sequence for the intergenic region between FGA and FGB, the site of the telomeric deletion break-point was unknown. The cloning and partial sequencing of this portion of chromosome 4q was therefore an essential prerequisite to the sequencing of the deletion junctions.
The strategy used to clone the FGA-FGB intergenic region is summarised in Figure 1 . We used long-range PCR to amplify this region from the genomic DNA of individuals from the Swiss family with congenital afibrinogenaemia, using forward primers in FGA exon 1 and reverse primers in FGB exon 7 (note the opposite orientations of the FGA and FGB genes). All products amplified from carrier individuals and afibrinogenaemia patients gave a single band of approximately 11.5 kb. No larger products were seen in amplifications from heterozygote deletion carriers: the In order to determine the normal sequence at the telomeric end of the deleted region, we performed a single PCR amplification from genomic DNA of heterozygous individuals using a forward primer in FGA exon 5 and a reverse primer designed from the novel intergenic sequence, FGbreak1R (Figure 1 , oligonucleotides 5 and 6). Figure 2 shows the sequence of the afibrinogenaemia deletion junction, with the corresponding normal sequences from FGA intron 1 (the centromeric breakpoint) and from the FGA-FGB intergenic sequence (the telomeric breakpoint). This deletion junction sequence was identical in all the affected individuals and in their heterozygous parents (this was confirmed with three different primer pairs, in independent PCR and sequencing experiments; data not shown).
The breakpoint is situated in a stretch of four Ts located in both FGA intron 1 and on the same DNA strand in the FGA-FGB intergenic sequence. The regions bordering the deletion breakpoint contain a number of sequence elements that have been implicated in the generation of human gene deletions (Figure 2a) . Firstly, the breakpoint is located in a 7-bp direct repeat, AACTTTT; one copy of the repeat persists on the deleted alleles, but with the deletion of a single T. Secondly, there is an imperfect inverted copy of this repeat (6 out of 7 nucleotides) immediately telomeric of the deletion junction. Thirdly, the breakpoints are surrounded by further inverted repeats: analysis with the computer program mfold identified one centromeric and two telomeric predicted stem-loop structures (Figure 2b) .
Previous haplotype data obtained with markers flanking the fibrinogen gene cluster suggested an independent origin for each of the deletions. We extended this haplotype analysis to include three new markers D4S3021, D4S2999 and D4S2631. In particular, the location of marker D4S3021 is indistinguishable from the location of FGB (0 cM between the two loci). The new haplotypes obtained continue to suggest the recurrence of the deletion, since, with the four most closely-linked flanking markers, three distinct haplotypes were found for the deleted chromosomes (Figure 3) , ie 3-2-del-2-3, 2-2-del-2-2 and 1-1-del-1-2 (this last haplotype being shared by the two fathers of the affected individuals). It remains possible that the two mutant alleles contributed by the mothers originated from the same ancestral allele, since the core haplotypes are identical, ie 2-del-2.
As the apparent recurrence of the deletion suggested the existence of a possible 'mutation hotspot', we screened 468 anonymised DNA samples (936 alleles) isolated from buccal smears from unrelated individuals from the Geneva region with no known coagulation problems. No deletion carrier individuals were identified, indicating that although this deletion may prove to be relatively common in afibrinogenaemia patients, it is very rare in the general population.
Discussion
The deletion responsible for congenital afibrinogenaemia in four affected members of the non-consanguineous Swiss family reported is in all probability due to non-homologous recombination between sites with limited homology, 9 which has been surmised to lead to various rearrangements such as deletions, insertions, inversions, duplications and translocations. Repetitive genomic elements such as Alu sequences have been shown to be responsible for deletions in delta 0 -beta 0 -thalassaemia 10 and familial hypercholesterolaemia.
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Recombination between non-repetitive, homologous sequences of several kilobases have also been described, for example with the F8 gene inversions in haemophilia A, 12 CYP21B deletions in congenital adrenal hyperplasia, 13 and alpha-globin gene deletions in alpha-thalassaemias. 14 In the case of the afibrinogenaemia deletion described here, no single long region of homology appears to be involved, but a number of short homologous sequences are present. The position of the breakpoint strongly suggests that the deletion is mediated by the two direct AACTTTT repeats. Meiotic recombination leading to deletion could have been facilitated by the various inverted repeats around the breakpoints; a heptamer repeat alone is unlikely to be sufficiently long to support crossing-over. 15 Slipped mispairing during DNA replication could also have led to the deletion; this mechanism is supported by the fact that only one direct repeat remains in the deleted allele, although an 11 kb deletion is large for such a mechanism. The loss of one thymidine at the deletion junction is unusual in large deletions, and is most easily explained by an error of DNA polymerase , which is responsible for repairing single-stranded nicks and which is known to be particularly error-prone in polypyrimidine tracts. 9 The single base deletion would therefore also support the slipped mispairing model in which a single-stranded loop between direct repeats is excised, and the nick is incorrectly repaired by DNA polymerase .
Do the three identical deletions in this family represent discrete historical mutational events, or have their haplotypes diverged by recombination or mutation from a common origin? The haplotypes derived Figure 3 are heterozygous at each of these four loci. At least two recombination events would therefore be necessary to derive these haplotypes from a common origin, between FGA and very tightly linked markers (θ = 0.00 and θ = 0.56 cM according to the Marshfield map). Less probably, the separate haplotypes could also have evolved from a common origin by four distinct mutations of the dinucleotide repeats. However, if this deletion were indeed a recurrent mutation, one would expect the disorder to be more common, whereas congenital afibrinogenaemia is extremely rare; in this respect, we studied nearly 1000 alleles from the local population, and found no further deleted alleles. It will not be possible to distinguish between these two hypotheses without widespread studies in afibrinogenaemia patients from various populations.
We have examined three afibrinogenaemia alleles of apparently independent origin, according to their haplotypes, revealing a deletion mediated by direct and perhaps by indirect repeats. This implies the existence of a relative 'hotspot' for deletion in the fibrinogen gene cluster. It is interesting to note that the first studies of the fibrinogen gene cluster in afibrinogenaemia patients by Southern blotting detected no deletions, 16 implying that further mutation mechanisms exist. It will consequently be of great interest to evaluate the frequency of the mutation amongst further afibrinogenaemia patients.
